Stay updated with breaking news from Nyse Bvs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kent Lake Capital LLC cut its holdings in Bioventus Inc. (NYSE:BVS – Free Report) by 48.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 532,880 shares of the company’s stock after selling 502,288 shares during the period. Kent Lake Capital LLC owned 0.68% of Bioventus […]
Canaccord Genuity Group upgraded shares of Bioventus (NYSE:BVS – Free Report) from a hold rating to a buy rating in a research note issued to investors on Thursday, Benzinga reports. The firm currently has $7.00 price objective on the stock, up from their prior price objective of $3.66. A number of other equities research analysts […]
Bioventus (NYSE:BVS – Get Free Report) is set to announce its earnings results before the market opens on Tuesday, November 7th. Analysts expect the company to announce earnings of $0.06 per share for the quarter. Bioventus has set its FY 2023 guidance at -$0.24–$0.20 EPS.Investors that are interested in registering for the company’s conference call […]
Bioventus (NYSE:BVS – Get Free Report) and Nuvectra (OTCMKTS:NVTRQ – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends. Profitability This table compares Bioventus and Nuvectra’s net margins, return […]
Bioventus Inc. (NYSE:BVS – Get Free Report) major shareholder Juniper Investment Company, Ll acquired 14,985 shares of the business’s stock in a transaction on Monday, August 14th. The shares were bought at an average cost of $4.79 per share, with a total value of $71,778.15. Following the completion of the acquisition, the insider now owns […]